- Home
- OGI vs CMPX Comparison
OGI vs CMPX Comparison
Compare OGI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- CMPX
- Stock Information
- Founded
- OGI 2013
- CMPX 2014
- Country
- OGI Canada
- CMPX United States
- Employees
- OGI N/A
- CMPX N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- OGI Health Care
- CMPX Health Care
- Exchange
- OGI Nasdaq
- CMPX Nasdaq
- Market Cap
- OGI 186.1M
- CMPX 291.8M
- IPO Year
- OGI N/A
- CMPX N/A
- Fundamental
- Price
- OGI $1.43
- CMPX $2.97
- Analyst Decision
- OGI
- CMPX Strong Buy
- Analyst Count
- OGI 0
- CMPX 9
- Target Price
- OGI N/A
- CMPX $12.67
- AVG Volume (30 Days)
- OGI 561.1K
- CMPX 839.1K
- Earning Date
- OGI 08-12-2025
- CMPX 08-11-2025
- Dividend Yield
- OGI N/A
- CMPX N/A
- EPS Growth
- OGI N/A
- CMPX N/A
- EPS
- OGI 0.10
- CMPX N/A
- Revenue
- OGI $135,031,829.00
- CMPX $850,000.00
- Revenue This Year
- OGI $50.30
- CMPX N/A
- Revenue Next Year
- OGI $16.01
- CMPX N/A
- P/E Ratio
- OGI $14.27
- CMPX N/A
- Revenue Growth
- OGI 20.49
- CMPX N/A
- 52 Week Low
- OGI $0.85
- CMPX $0.87
- 52 Week High
- OGI $2.08
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- OGI 54.79
- CMPX 66.60
- Support Level
- OGI $1.36
- CMPX $2.64
- Resistance Level
- OGI $1.50
- CMPX $3.00
- Average True Range (ATR)
- OGI 0.06
- CMPX 0.18
- MACD
- OGI 0.00
- CMPX 0.02
- Stochastic Oscillator
- OGI 63.16
- CMPX 90.00
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.